Intergroupe Francophone Du Myelome
Intergroupe Francophone Du Myelome (IFM) is a leading organisation dedicated to advancing research and treatment for multiple myeloma. Headquartered in France, IFM operates across various Francophone regions, fostering collaboration among healthcare professionals and researchers. Established in 2000, the organisation has achieved significant milestones in clinical trials and therapeutic advancements. IFM focuses on promoting innovative research, developing clinical guidelines, and enhancing patient care in the field of myeloma. Its unique approach combines scientific expertise with a commitment to improving patient outcomes, positioning it as a key player in the haematology sector. Notably, IFM has contributed to numerous groundbreaking studies, solidifying its reputation as a trusted authority in multiple myeloma research and treatment.
DitchCarbon Score
How does Intergroupe Francophone Du Myelome's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Instruments industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Intergroupe Francophone Du Myelome's score of 26 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Intergroupe Francophone Du Myelome's reported carbon emissions
Intergroupe Francophone Du Myelome currently does not have available carbon emissions data for recent years, as no specific figures have been reported. Additionally, there are no documented reduction targets or initiatives outlined in their climate commitments. This absence of data suggests that the organisation may still be in the early stages of developing a comprehensive climate strategy or reporting framework. In the context of the industry, it is increasingly important for organisations to establish clear carbon reduction goals and track emissions across all scopes (Scope 1, 2, and 3) to align with global climate standards. As the focus on sustainability intensifies, Intergroupe Francophone Du Myelome may benefit from setting measurable targets and engaging in initiatives that contribute to reducing their carbon footprint in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Intergroupe Francophone Du Myelome is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
